Literature DB >> 23681613

Neural induction with a dopaminergic phenotype from human pluripotent stem cells through a feeder-free floating aggregation culture.

Asuka Morizane1, Daisuke Doi, Jun Takahashi.   

Abstract

Pluripotent stem cells are promising potential sources for cell replacement therapy and are useful research tools for exploring disease mechanisms. Neural cells are one of the cell types that have been most efficiently differentiated through several established protocols. This chapter describes the feeder-free floating aggregation culture system for the induction of dopaminergic neurons. This method is simple and highly efficient for the production of dopaminergic neurons. It has several advantages for application in clinical usage in comparison to the other protocols using either feeder cells or Matrigel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681613     DOI: 10.1007/978-1-62703-444-9_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.

Authors:  Priya Srikanth; Tracy L Young-Pearse
Journal:  J Neurogenet       Date:  2014-03-17       Impact factor: 1.250

2.  Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2.

Authors:  Takeshi Hatani; Shunsuke Funakoshi; Thomas J Deerinck; Eric A Bushong; Takeshi Kimura; Hiroshi Takeshima; Mark H Ellisman; Masahiko Hoshijima; Yoshinori Yoshida
Journal:  Biochem Biophys Res Commun       Date:  2018-10-15       Impact factor: 3.575

3.  MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells.

Authors:  Callum J C Parr; Shota Katayama; Kenji Miki; Yi Kuang; Yoshinori Yoshida; Asuka Morizane; Jun Takahashi; Shinya Yamanaka; Hirohide Saito
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

4.  Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases.

Authors:  Keiko Sugai; Ryuji Fukuzawa; Tomoko Shofuda; Hayato Fukusumi; Soya Kawabata; Yuichiro Nishiyama; Yuichiro Higuchi; Kenji Kawai; Miho Isoda; Daisuke Kanematsu; Tomoko Hashimoto-Tamaoki; Jun Kohyama; Akio Iwanami; Hiroshi Suemizu; Eiji Ikeda; Morio Matsumoto; Yonehiro Kanemura; Masaya Nakamura; Hideyuki Okano
Journal:  Mol Brain       Date:  2016-09-19       Impact factor: 4.041

5.  Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.

Authors:  Junko Ueki; Masayuki Nakamori; Masahiro Nakamura; Misato Nishikawa; Yoshinori Yoshida; Azusa Tanaka; Asuka Morizane; Masayoshi Kamon; Toshiyuki Araki; Masanori P Takahashi; Akira Watanabe; Nobuya Inagaki; Hidetoshi Sakurai
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

6.  First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol.

Authors:  Keiko Sugai; Miho Sumida; Tomoko Shofuda; Ryo Yamaguchi; Takashi Tamura; Tsuneo Kohzuki; Takayuki Abe; Reo Shibata; Yasuhiro Kamata; Shuhei Ito; Toshiki Okubo; Osahiko Tsuji; Satoshi Nori; Narihito Nagoshi; Shinya Yamanaka; Shin Kawamata; Yonehiro Kanemura; Masaya Nakamura; Hideyuki Okano
Journal:  Regen Ther       Date:  2021-09-07       Impact factor: 3.419

7.  Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease.

Authors:  Benjamin M Hiller; David J Marmion; Cayla A Thompson; Nathaniel A Elliott; Howard Federoff; Patrik Brundin; Virginia B Mattis; Christopher W McMahon; Jeffrey H Kordower
Journal:  NPJ Regen Med       Date:  2022-04-21

8.  Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivo.

Authors:  Benjamin M Hiller; David J Marmion; Rachel M Gross; Cayla A Thompson; Carrie A Chavez; Patrik Brundin; Dustin R Wakeman; Christopher W McMahon; Jeffrey H Kordower
Journal:  Stem Cells Transl Med       Date:  2020-09-30       Impact factor: 6.940

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.